Therapetic targeting of Glucose pathways: Anticancer drug Epirubicin inhibits Glucose phosphate isomerase expression via up regulation of its target gene, 29/October/2013, 6.26 am

Therapetic targeting of Glucose pathways: Anticancer drug Epirubicin inhibits Glucose phosphate isomerase expression via up regulation of its target gene, 29/October/2013, 6.26 am

Therapetic targeting of Glucose pathways: Anticancer drug Epirubicin inhibits Glucose phosphate isomerase expression via up regulation of its target gene, 29/October/2013, 6.26 am 150 150

Idea Proposed by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Therapetic targeting of Glucose pathways: Anticancer drugEpirubicin inhibits Glucose phosphate isomerase  expression via up regulation of its target gene, 29/October/2013, 6.26 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Share
Start Typing